XS
SM
MD
LG
XL
Regulatory News

Director/PDMR Shareholding

RNS Number : 3055M
Darktrace PLC
20 May 2022
 

20th May 2022

Darktrace plc

("Darktrace")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Darktrace announces that it has been notified of the following PDMR transactions.

Gordon Hurst, Chair, has notified Darktrace that on 20th May 2022 he purchased 55,000 ordinary shares in Darktrace at an aggregate price of 368.7 pence per share.

Details of PDMR / person closely associated with them ("PCA")

Name

Gordon Hurst

Reason for the notification

Position / status

Chair

Initial notification / amendment

Initial Notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Darktrace plc

LEI

213800PC5S5P9CSNFC89

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Date of transaction

Financial Instrument

Identification Code

Place of Transaction

Currency

2022-05-20

Ordinary shares

DARK

London Stock Exchange

GBP - British Pound

Nature Of Transaction:

 

Purchase of shares

 


Price(s)

Volume(s)

 Total


3.69

55000

 202785.00

  Aggregated

3.687

55000

 202785.00

 

 

Contact:

Luk Janssens - Head of Investor Relations, Darktrace

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAASEAFEAEFA